Electronic ISSN 2287-0237

VOLUME

HETEROGENEITY OF UNILATERAL MULTIPLE BREAST CANCER: IMPLICATIONS FOR BIOMARKER TESTING

SEPTEMBER 2014 - VOL.8 | ORIGINAL ARTICLE
  1. Agelopoulos K, Tidow N, Korsching E, et al. Molecular cytogenetic investigations of synchronous bilateral breast  cancer. J Clin Pathol 2003;56:660-5.
  2. Tavassoli F. Pathology of the Breast. 2nd ed. New York, McGraw-Hill 1999:56-8.
  3. Middleton LP, Vlastos G, Mirza NQ, et al. Multicentric mammary carcinoma:evidence of monoclonal prolife-   ration. Cancer 2002;94:1910-6.
  4. Nakamura R, Song JP, Isogaki J, et al. Multiple (multi-centric and multifocal) cancers in the ipsilateral breast    with different histologies: profiles of chromosomal  numerical abnormality. Jpn J Clin Oncol 2003;33:463-9.
  5. Noguchi S, Aihara T, Koyama H, et al. Discrimination between multicentric and multifocal carcinomas of the    breast through clonal analysis. Cancer 1994;74:872-7.
  6. Teixeira MR, Pandis N, Bardi G, et al. Discrimination between multicentric and multifocal breast carcinoma by cytogenetic investigation of macroscopically distinct ipsilateral lesions. Genes Chromosomes Cancer 1997;18:170-4.
  7. Teixeira MR, Pandis N, Bardi G, et al. Cytogenetic analysis of multifocal breast carcinomas: detection of karyotypically unrelated clones as well as clonal simila- rities between tumor foci. Br J Cancer 1994;70:922-7.
  8. Teixeira MR, Ribeiro FR, Torres L, et al. Assessment of  clonal relationships in ipsilateral and bilateral multiple breast carcinomas by comparative genomic hybridisation and hierarchical clustering analysis. Br J Cancer 2004; 91:775-82.
  9. Tse GM, Kung FY, Chan AB, et al. Clonal analysis of bilateral mammary carcinomas by clinical evaluation and partial allelotyping. Am J Clin Pathol 2003;120:168-74.
  10. Tsuda H, Hirohashi S. Identification of multiple breast cancers of multicentric origin by histological observa-  tions and distribution of allele loss on chromosome 16q. Cancer Res 1995;55:3395-8.   
  11. Lakhani SR, Ellis IO, Schnitt SJ, et al. WHO Classifi-cation of Tumors of the Breast. IARC Press:Lyon, 2012   
  12. Wolff AC, Hammond ME, Hicks DG, et al. Recommen-dations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol 2013;31:3997-4013.   
  13. Amari M, Moriya T, Ishida T, et al. Loss of heterozy-gosity analyses of asynchronous lesions of ductal carci-noma in situ and invasive ductal carcinoma of the human breast. Jpn J Clin Oncol 2003; 33: 556-62.   
  14. Taback B, Giuliano AE, Hansen NM, et al. Detection of  tumor-specific genetic alterations in bone marrow from early-stage breast cancer patients. Cancer Res 2003;63:1884-7.   
  15. Zhu W, Qin W, Ehya H, et al. Microsatellite changes in nipple aspirate fluid and breast tissue from women with breast carcinoma or its precursors. Clin Cancer Res 2003;9:3029-33.   
  16. Mutirangura A, Charuruks N, Shuangshoti S, et al. Iden-tification of distinct regions of allelic loss on chromo-some 13q in nasopharyngeal carcinoma from paraffin embedded tissues. Int J Cancer 1999;83:210-4.   
  17. Shuangshoti S, Navalitloha Y, Kasantikul V, et al. Genetic heterozygosity and progression in different areas within high-grade diffuse astrocytoma. Oncol Rep 2000;7:113-7.   
  18. Wild PJ, Reichle A, Andreesen R, et al. Microsatellite instability predicts poor short-term survival in patients with advanced breast cancer after high-dose chemotherapy and autologous stem-cell transplantation. Clin Cancer Res 2004;10:556-4.
SEARCH VOLUME & NUMBER
GO
RECENT VOLUME & NUMBER